Search Results for: us stem cell

Big stem cell news: dynamic duo of all-chemical direct reprogramming reports

Neurons-created-from-ciNSC

What is direct reprogramming ? There’s some big, positive news on this stem cell front today. All chemical direct reprogramming Two new innovative papers both by teams led by Sheng Ding of Gladstone Institutes with UCSF report all-chemical direct reprogramming of human somatic cells. Ding’s team took skin cells and by exposing them to cocktails of […]

Big stem cell news: dynamic duo of all-chemical direct reprogramming reports Read More »

Perspectives on Vatican Stem Cell Meeting: CIRM, Embryonic & Adult Stem Cells

Vatican-stem-cell-meeting

What is a Vatican Stem Cell Meeting like? Over the years, the Vatican has expressed interest and even invested money in the adult stem cell field. Not surprisingly, they’ve also been critical of embryonic stem cell research. Interestingly their own stem cell meetings have at times stimulated heated debate for various reasons and one was even cancelled with

Perspectives on Vatican Stem Cell Meeting: CIRM, Embryonic & Adult Stem Cells Read More »

Pain in a dish? Drug testing bench to bedside with IPS cells

inherited-erythromelalgia

A new study on treating pain with a unique stem cell connection caught my attention. The paper was from a team at Pfizer led by Edward B. Stevens. Talk about bench to bedside, these researchers went all the way from patients to patient somatic cells to reprogrammed IPSC to neurons to model pain in a dish

Pain in a dish? Drug testing bench to bedside with IPS cells Read More »

Will there be a Theranos of the stem cell field?

Theranos

Blood testing biotech Theranos finds itself in a hole that seemingly just keeps getting deeper with the report today that the company is under criminal investigation. Can it bounce back? Some people are really upset with Theranos for allegedly making misleading statements including both to investors and the government about its technologies. It’s no exaggeration

Will there be a Theranos of the stem cell field? Read More »

New Mitalipov paper on stem cell mitochondria: challenge for IPS cell field?

Mitalipov-mitochondrial-mutations

A new paper from Shoukhrat Mitalipov’s lab on stem cell mitochondria points to a pattern whereby induced pluripotent stem (IPS) cells tend to have more problems if they are from older patients. New Mitalipov paper What does this paper mean for the stem cell field and could it impact more specifically the clinical applications of IPS

New Mitalipov paper on stem cell mitochondria: challenge for IPS cell field? Read More »

Where are ES cell foes James Sherley & Theresa Deisher now?

Theresa-Deisher

Four or five years ago the top stem cell story was the battle over federal funding of human embryonic stem (ES) cell research in the U.S. by James Sherley and Theresa Deisher. They were the two opponents of ES cell research making the most national headlines. Nature did a whole piece back then on Deisher

Where are ES cell foes James Sherley & Theresa Deisher now? Read More »

Do for-profit stem cell studies have inherent potential biases?

There’s been an interesting and diverse discussion going on here on this blog lately related to some stem cell translational things including a stem cell clinic operating in Sacramento (see 50+ comments on that post) and then more recently on a new paper from the Centeno clinic. .@pknoepfler Did most (or all) participants in this study pay

Do for-profit stem cell studies have inherent potential biases? Read More »

Review of Centeno MSC safety paper: without controls, conclusions muted

Centeno-Table-3

The number of people around the world being injected with stem cells every day has never been higher and the heterogeneous group of medical providers doing these procedures is also at or near its highest level ever. The cells used are also highly variable as are the procedures themselves, but most of these cells fall under the

Review of Centeno MSC safety paper: without controls, conclusions muted Read More »

Keys to successful stem cell translation – Nurses, physicians and patient advocates

Adrienne-Bell-Cors

Editor’s note: this is a guest post on stem cell translation. By Heather Main I recently attended the UCSD Health CIRM Alpha Stem Cell Clinics Network Symposium at the Sanford Consortium, San Diego. There was of course some great academic research presented, including conflicting views on liver stem cell compartments from Roel Nusse and David

Keys to successful stem cell translation – Nurses, physicians and patient advocates Read More »